These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8382972

  • 1. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors.
    Solary E, Bertrand R, Kohn KW, Pommier Y.
    Blood; 1993 Mar 01; 81(5):1359-68. PubMed ID: 8382972
    [Abstract] [Full Text] [Related]

  • 2. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
    Bertrand R, Solary E, Jenkins J, Pommier Y.
    Exp Cell Res; 1993 Aug 01; 207(2):388-97. PubMed ID: 7688316
    [Abstract] [Full Text] [Related]

  • 3. Apoptosis of human leukemic HL-60 cells induced to differentiate by phorbol ester treatment.
    Solary E, Bertrand R, Pommier Y.
    Leukemia; 1994 May 01; 8(5):792-7. PubMed ID: 8182936
    [Abstract] [Full Text] [Related]

  • 4. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
    Zwelling LA, Chan D, Hinds M, Mayes J, Silberman LE, Blick M.
    Cancer Res; 1988 Dec 01; 48(23):6625-33. PubMed ID: 2846155
    [Abstract] [Full Text] [Related]

  • 5. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
    Ling YH, Andersson BS, Nelson JA.
    Cancer Biochem Biophys; 1990 Jan 01; 11(1):23-30. PubMed ID: 2159843
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent.
    Ellis AL, Nowak B, Plunkett W, Zwelling LA.
    Cancer Chemother Pharmacol; 1994 Jan 01; 34(3):249-56. PubMed ID: 8004759
    [Abstract] [Full Text] [Related]

  • 9. Topoisomerase inhibitors induce apoptosis in thymocytes.
    Onishi Y, Azuma Y, Sato Y, Mizuno Y, Tadakuma T, Kizaki H.
    Biochim Biophys Acta; 1993 Jan 17; 1175(2):147-54. PubMed ID: 8380339
    [Abstract] [Full Text] [Related]

  • 10. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells.
    Solary E, Bertrand R, Pommier Y.
    Leuk Lymphoma; 1994 Sep 17; 15(1-2):21-32. PubMed ID: 7858500
    [Abstract] [Full Text] [Related]

  • 11. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
    Dubrez L, Goldwasser F, Genne P, Pommier Y, Solary E.
    Leukemia; 1995 Jun 17; 9(6):1013-24. PubMed ID: 7596166
    [Abstract] [Full Text] [Related]

  • 12. Apoptosis of S-phase HL-60 cells induced by DNA topoisomerase inhibitors: detection of DNA strand breaks by flow cytometry using the in situ nick translation assay.
    Gorczyca W, Melamed MR, Darzynkiewicz Z.
    Toxicol Lett; 1993 Apr 17; 67(1-3):249-58. PubMed ID: 8383887
    [Abstract] [Full Text] [Related]

  • 13. In vitro treatment with retinoids or the topoisomerase inhibitor, VP-16, evidences different functional apoptotic pathways in acute promyelocytic leukemic cells.
    Calabresse C, Barbey S, Venturini L, Balitrand N, Degos L, Fenaux P, Chomienne C.
    Leukemia; 1995 Dec 17; 9(12):2049-57. PubMed ID: 8609716
    [Abstract] [Full Text] [Related]

  • 14. All-trans retinoic acid reverses phorbol ester resistance in a human myeloid leukemia cell line.
    Yang KD, Mizobuchi T, Kharbanda SM, Datta R, Huberman E, Kufe DW, Stone RM.
    Blood; 1994 Jan 15; 83(2):490-6. PubMed ID: 8286746
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation.
    Ohta H, Sweeney EA, Masamune A, Yatomi Y, Hakomori S, Igarashi Y.
    Cancer Res; 1995 Feb 01; 55(3):691-7. PubMed ID: 7834642
    [Abstract] [Full Text] [Related]

  • 17. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression.
    Bertrand R, Sarang M, Jenkin J, Kerrigan D, Pommier Y.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6280-5. PubMed ID: 1933888
    [Abstract] [Full Text] [Related]

  • 18. [Apoptosis of human leukemic cells induced by topoisomerase I and II inhibitors].
    Solary E, Dubrez L, Eymin B, Bertrand R, Pommier Y.
    Bull Cancer; 1996 Mar 01; 83(3):205-12. PubMed ID: 8695922
    [Abstract] [Full Text] [Related]

  • 19. Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis.
    Sordet O, Rébé C, Leroy I, Bruey JM, Garrido C, Miguet C, Lizard G, Plenchette S, Corcos L, Solary E.
    Blood; 2001 Jun 15; 97(12):3931-40. PubMed ID: 11389037
    [Abstract] [Full Text] [Related]

  • 20. Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
    Kaufmann SH.
    Cancer Res; 1991 Feb 15; 51(4):1129-36. PubMed ID: 1705167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.